Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2005 | 1 |
2019 | 1 |
2022 | 3 |
2023 | 2 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
williams j dalton[Author]
(4 results)?
How low risk are low risk myelodysplastic syndromes?
Expert Rev Hematol. 2022 Jan;15(1):15-24. doi: 10.1080/17474086.2022.2029698. Epub 2022 Jan 24.
Expert Rev Hematol. 2022.
PMID: 35041576
Review.
Co-occurring mutations in ASXL1, SRSF2, and SETBP1 define a subset of myelodysplastic/ myeloproliferative neoplasm with neutrophilia.
Jain T, Ware AD, Dalton WB, Pasca S, Tsai HL, Gocke CD, Gondek LP, Xian RR, Borowitz MJ, Levis MJ.
Jain T, et al.
Leuk Res. 2023 Aug;131:107345. doi: 10.1016/j.leukres.2023.107345. Epub 2023 Jun 21.
Leuk Res. 2023.
PMID: 37354804
Item in Clipboard
Venetoclax in combination with hypomethylating agent for the treatment of advanced myeloproliferative neoplasms and acute myeloid leukemia with extramedullary disease.
Sanber K, Ye K, Tsai HL, Newman M, Webster JA, Gojo I, Ghiaur G, Prince GT, Gondek LP, Smith BD, Levis MJ, DeZern AE, Ambinder AJ, Dalton WB, Jain T.
Sanber K, et al. Among authors: dalton wb.
Leuk Lymphoma. 2023 Apr;64(4):846-855. doi: 10.1080/10428194.2023.2173523. Epub 2023 Feb 6.
Leuk Lymphoma. 2023.
PMID: 36744656
Item in Clipboard
Taking the STING out of acute myeloid leukemia through macrophage-mediated phagocytosis.
Dalton WB, Ghiaur G, Resar LM.
Dalton WB, et al.
J Clin Invest. 2022 Mar 1;132(5):e157434. doi: 10.1172/JCI157434.
J Clin Invest. 2022.
PMID: 35229728
Free PMC article.
Item in Clipboard
Post-Transplantation Cyclophosphamide-Based Graft- versus-Host Disease Prophylaxis with Nonmyeloablative Conditioning for Blood or Marrow Transplantation for Myelofibrosis.
Jain T, Tsai HL, DeZern AE, Gondek LP, Elmariah H, Bolaños-Meade J, Luznik L, Fuchs E, Ambinder R, Gladstone DE, Imus P, Webster J, Prince G, Ghiaur G, Smith BD, Ali SA, Ambinder A, Dalton WB, Gocke CB, Huff CA, Gojo I, Swinnen L, Wagner-Johnston N, Borrello I, Varadhan R, Levis M, Jones RJ.
Jain T, et al. Among authors: dalton wb.
Transplant Cell Ther. 2022 May;28(5):259.e1-259.e11. doi: 10.1016/j.jtct.2022.02.004. Epub 2022 Feb 11.
Transplant Cell Ther. 2022.
PMID: 35158092
Free PMC article.
Item in Clipboard
Fibrinogen consumption and use of heparin are risk factors for delayed bleeding during acute promyelocytic leukemia induction.
Hambley BC, Norsworthy KJ, Jasem J, Zimmerman JW, Shenderov E, Webster JA, Showel MM, Gondek LP, Dalton WB, Prince G, Gladstone DE, Streiff MB, Pratz KW, Gojo I, Ghiaur G, Levis MJ, Smith BD, DeZern AE.
Hambley BC, et al. Among authors: dalton wb.
Leuk Res. 2019 Aug;83:106174. doi: 10.1016/j.leukres.2019.106174. Epub 2019 Jun 21.
Leuk Res. 2019.
PMID: 31255938
Clinical Trial.
No abstract available.
Item in Clipboard
Krüppel-like factor 4 prevents centrosome amplification following gamma-irradiation-induced DNA damage.
Yoon HS, Ghaleb AM, Nandan MO, Hisamuddin IM, Dalton WB, Yang VW.
Yoon HS, et al.
Oncogene. 2005 Jun 9;24(25):4017-25. doi: 10.1038/sj.onc.1208576.
Oncogene. 2005.
PMID: 15806166
Free PMC article.
Item in Clipboard
Cite
Cite